United States: Bacterial infections caused by Mycoplasma pneumoniae have been increasing in the United States since likely to be in the late spring. Many patients are being sent home from emergency departments with pneumonia or acute bronchitis which are ultimately linked to this infection, and the numbers which almost reached their highest point in late August.
M. pneumoniae has recently increased in circulation and CDC continues to monitor this change in multiple demographics, severity of illness, and outcome indicators compared to those illnesses prior to COVID-19. CDC is also contacting clinicians and health departments regarding the rise of M. pneumoniae infection and working on antibiotic surveillance.
M. pneumoniae are bacteria that may cause pneumonia.
As reported by the official website of CDC, Mycoplasma pneumoniae is a relatively refined organism, commonly associated with mild respiratory disorder. For the past few weeks after the start of late spring, the cases of M. pneumoniae have constantly circulated in especially the young children. This is already like very much different from previous years where published research showed most of the infections were contracted by school going children and adolescents.
Mycoplasma is a absolutely genus of bacteria that can basically colonize various areas of the body M pneumoniae comes under mycoplasma, and it causes respiratory illness. It can harm the epithelial layer of the respiratory tracts starting from the throat, trachea, to the lungs.
M pneumoniae is typically mild and many cases manifest as an upper respiratory infection similar to a flu exclusively failing which pneumonia. The onset of the disease is insidious and may be accompanied by fever, cough, sore throat and other symptoms. If the infection develops pneumonia, the pneumonia is generally of a less virulent form of bacterial pneumonia that has popularly been termed, ‘walking pneumonia’.
Rare instances however may lead to complications that require admission for treatment as new or worsening asthma, severe pneumonia or encephalitis. M. pneumoniae is an important etiologic agent of bacterial infection in those who require hospitalization on account of CAP.
G. M. pneumoniae infections are possible for people of all ages but are most common in children between the ages of 5 and 17 years and young adults. I take sugar that younger children would present different symptoms such as diarrhea, wheezing, or vomiting.
In the year 2023 M Pneumoniae began to re-emerge globally after a prolonged period of low incidence of the infections since the start of the COVID-19 pandemic and here CDC routinely monitors or take surveillance the emergency department case of the people with the pneumoniae infections which may occur more often in the summer and early fall.